Women with PMOS should get subsidised weight loss drugs, advocates say

Sources

Coverage

Limited spectrum

Sentiment

0.00

◀ Left 100%Centre 0%Right 0% ▶

How we rate bias →

This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.

shopping_bagUK Politics & Current Affairs Books

Go deeper than the headlines with books from journalists and historians covering British politics.

Browse books on Amazonarrow_forward

NewsDeck Poll

Do you think this story is being covered fairly across the political spectrum?

Loading…

Left

(1)

Guardian World

Women with PMOS should get subsidised weight loss drugs, advocates say

With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label Get our breaking news email, free app or daily news podcast Women living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say. The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be appr…